Tirzepatide 10mg
Tirzepatide from 1bmf Labz is being sold as a *Research Chemical and requires you to reconstitute it with Bacteriostatic Water. Be sure to add Bacteriostatic Water to your cart.
Tirzepatide injections are FDA-approved GLP-1 agonist medications used to treat obesity and aid in dramatic weight loss. Tirzepatide is a once-weekly injections that require no change in diet or lifestyle to produce weight loss results of greater than 50 lbs in as little as 6 months. When used along with an individualized low-calorie, low-fat diet, and exercise program to help with weight loss, overweight adults who may also have high blood pressure, diabetes, or high cholesterol see significant progress across all health markers. Tirzepatide injections are a class of medications called glucagon-like-peptide-1 (GLP-1) agonists, although Tirzepatide has enhanced effects as a glucose-dependent insulinotropic polypeptide (GIP) agonist that produce more drastic weight loss results.
Mechanism of action
It works to stimulate first- and second-phase insulin secretion, and reduces glucagon levels, both in a glucose-dependent manner. Tirzepatide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake, 4 and reduce body weight in patients with type 2 diabetes.
Tirzepatide from 1bmf Labz is being sold as a *Research Chemical and requires you to reconstitute it with Bacteriostatic Water. Be sure to add Bacteriostatic Water to your cart.
Tirzepatide injections are FDA-approved GLP-1 agonist medications used to treat obesity and aid in dramatic weight loss. Tirzepatide is a once-weekly injections that require no change in diet or lifestyle to produce weight loss results of greater than 50 lbs in as little as 6 months. When used along with an individualized low-calorie, low-fat diet, and exercise program to help with weight loss, overweight adults who may also have high blood pressure, diabetes, or high cholesterol see significant progress across all health markers. Tirzepatide injections are a class of medications called glucagon-like-peptide-1 (GLP-1) agonists, although Tirzepatide has enhanced effects as a glucose-dependent insulinotropic polypeptide (GIP) agonist that produce more drastic weight loss results.
Mechanism of action
It works to stimulate first- and second-phase insulin secretion, and reduces glucagon levels, both in a glucose-dependent manner. Tirzepatide was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake, 4 and reduce body weight in patients with type 2 diabetes.